Stem cell debate: now IVF is under threat
17 September, 2002 by Melissa TrudingerThe Federal House of Representatives agreed in principle on Monday night to pass the Research Involving Embryos Bill, voting 103 in favour to 36 against. But debate continued on the controversial bill as the first of a series of amendments was proposed.
New doubts cast on adult stem cell potential
06 September, 2002 by Melissa TrudingerResearchers at Stanford University Medical Center in the US have reported that they failed in attempts to coax adult blood-forming stem cells in mice into forming tissues other than blood and immune cells.
From footy to neuroscience: CogState branches out
05 September, 2002 by Melissa TrudingerA Melbourne company, whose test to measure cognitive abilities counts AFL teams among its customers, is branching out into biotech to develop neuroscience therapeutics.
Singapore govt awards grant to Agenix subsidiary
30 August, 2002 by Pete YoungA Singapore government decision to award a major grant to a subsidiary of Australian listed biotech Agenix is being labelled a "great vote of confidence" by Agenix CEO Don Home.
Stem cell Bill split but debate continues
30 August, 2002 by Pete YoungThe stem cell debate is likely to reach new levels of intensity in the wake of the vote splitting legislation permitting embryonic stem cell research from a bill outlawing human cloning.
Interview: DeVore takes the reins at stem cell centre
26 August, 2002 by Melissa TrudingerA few months ago, Dianna DeVore was an associate director of patents at Irish pharmaceutical company Elan in San Francisco. Now she's the chief operating officer of the National Centre for Stem Cells, Australia's first biotechnology Centre of Excellence.
Top scientist backs both adult and embryonic cell research
22 August, 2002 by Melissa TrudingerLeading scientist Catherine Verfaillie has told a briefing in Melbourne it was "unfortunate" that her work was held up as evidence that embryonic stem cell research was unnecessary.
Get it together on stem cells, warns Macfarlane
21 August, 2002 by Iain ScottIndustry Minister Ian Macfarlane last night warned scientists that the real threat to the future of stem cell research in Australia was because of researchers' conflicting goals.
Cellestis posts fourfold jump in revenue
09 August, 2002 by Tanya HollisInfectious disease detection test developer Cellestis has posted a greater than fourfold jump in revenue to end the full year at $583,000.
Euro decision disappoints Stem Cell Sciences
07 August, 2002 by Melissa TrudingerA decision by the European Patent Office (EPO) to revise the controversial 'Edinburgh' patent to exclude embryonic stem cells has disappointed Australian company Stem Cell Sciences.
Human-derived feeder cells used to grow human stem cells
05 August, 2002 by Tanya HollisResearchers have for the first time successfully grown human stem cells without exposure to mouse feeder cells.
Companies debate cell line R&D needs
01 August, 2002 by Melissa TrudingerExecutives of three leading stem cell research companies - Stem Cell Sciences CEO Peter Mountford, ES Cell International (ESI) CEO Robert Klupacs and BresaGen medical director Chris Juttner - have debated the need for new human embryonic stem cell lines and the availability of commercially owned cell lines for basic research.
Diversity will be key to Centre of Excellence success: DeVore
31 July, 2002 by Melissa TrudingerMulti-disciplinary research will be crucial to the success of the Centre for Stem Cell and Tissue Repair, its new chief operating officer told a Melbourne stem cell conference yesterday.
Controversies dissuade stem cell researchers, says NIH director
31 July, 2002 by Melissa TrudingerThe deputy director for extramural research at the US National Institutes of Health (NIH) warned delegates at a stem cell conference in Melbourne yesterday that the high level of attention being paid to the controversial research was making it difficult to attract scientists to work in the field.
NHMRC readies itself for new stem cell laws
31 July, 2002 by Melissa TrudingerNational Health and Medical Research Council CEO Prof Alan Pettigrew told a stem cell conference in Melbourne yesterday that the council was already preparing to implement a new embryonic stem cell research and cloning Bill.
